Related Experiment Videos
[Comments on anesthesia procedures in mitochondrial encephalomyopathy]
1Klinik für Anästhesiologie und Transfusionsmedizin der Universität Tübingen.
Abstract:
Mitochondrial encephalomyopathies (MEMP) are rare diseases caused by a disturbance of the mitochondrial chain of respiration. This prevents pyruvate from being completely integrated into the tricarboxylic acid (Krebs') cycle, and hence there is an accumulation of lactate. Histologically this is marked by the appearance of "ragged red fibres" in the light microscope which, in the electron microscope, are eventually recognised as typical accumulations of pathological mitochondria. The clinical pattern can vary greatly and ranges from ophthalmoplegia via mainly myopathic to encephalopathic forms. The pattern of signs and symptoms enables subclassification into three main syndromes (10): The Kearns-Sayre syndrome (KSS), "myoclonus epilepsy with ragged red fibres syndrome" (MERRF) and "mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes syndrome" (MELAS). Intermediate types, however, are frequent. Furthermore, quite a large number of other syndromes such as the "Toni-Fanconi-Debré syndrome" can be classified among the group of mitochondrial encephalomyopathies.--The patient must be classified as a risk patient. Disturbances of cardiac conduction may require a transient or permanent pacemaker. Increase in oxygen requirement must be avoided to prevent increase in lactate levels and development of lactate acidosis. The severity of the myopathy makes it necessary to exercise caution in the use of benzodiazepines and long-term relaxants. When using local anaesthetics one should consider both their negative dromotropism and the resulting reduction of the epileptic threshold. There is a relative contraindication for spinal and epidural anaesthesia.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Mitochondrial encephalomyopathies (MEMP) are rare genetic disorders affecting cellular energy production, leading to lactate buildup. Understanding their diverse clinical presentations and specific management needs is crucial for patient care.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Context:
- Mitochondrial encephalomyopathies (MEMP) are rare genetic disorders stemming from mitochondrial respiratory chain dysfunction.
- This dysfunction impairs pyruvate metabolism, leading to lactate accumulation and characteristic "ragged red fibres" on histological examination.
- Clinical manifestations are highly variable, ranging from ophthalmoplegia to myopathic and encephalopathic forms.
Purpose:
- To outline the pathophysiology of mitochondrial encephalomyopathies.
- To describe the classification of MEMP into distinct syndromes like Kearns-Sayre syndrome (KSS), MERRF, and MELAS.
- To highlight critical clinical considerations for managing patients with MEMP, including anesthetic risks and potential cardiac complications.
Summary:
- MEMP result from defects in the mitochondrial respiratory chain, causing impaired energy production and lactic acidosis.
- Histological findings include "ragged red fibres" due to abnormal mitochondrial accumulation.
- Key syndromes include KSS, MERRF, and MELAS, with frequent intermediate forms.
- Patient management requires careful consideration of cardiac conduction disturbances, oxygen requirements, and cautious use of sedatives and anesthetics due to potential risks.
Impact:
- Provides a comprehensive overview of mitochondrial encephalomyopathies for clinicians and researchers.
- Emphasizes the importance of recognizing diverse clinical phenotypes and specific diagnostic markers.
- Offers critical guidance on risk stratification and anesthetic management in patients with MEMP.